While the medical community agrees that immune cells inside a tumor leads to improved health outcome, for a subset of colorectal cancer patients, having too much of a good thing—too many immune cells—is a strong predictor ...
Sep 16, 2019
0
2
A new study by University of Kentucky Markey Cancer Center researchers provides new insight on targeted therapy for colorectal cancer metastasis.
Sep 16, 2019
0
7
Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment.
Sep 12, 2019
0
4
The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development. Mutated KRAS genes ...
Sep 11, 2019
0
2
A new American Cancer Society study finds that colorectal cancer (CRC) incidence is increasing exclusively in young adults in nine high-income countries spanning three continents. The study, appearing in the journal Gut, ...
Sep 05, 2019
0
19
Kentucky has the highest rate of lung cancer in the country, and is the leading cause of cancer-related death in the United States. It claims more lives each year than breast, prostate and colorectal cancers combined. With ...
Sep 04, 2019
0
1
Offering patients the choice between home screening or in-office colonoscopy does not increase participation in colorectal cancer screening, according to a new Penn Medicine study. However, the framing of choice did impact ...
Aug 30, 2019
0
11
Colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more vulnerable to chemotherapy. That's according to new Mayo Clinic research.
Aug 26, 2019
0
10
The effects of more than 60 minutes of moderate daily physical exercise, such as walking, accumulate throughout life and are associated with a 39 percent reduction in the risk of advanced adenomatous polyps, a precursor of ...
Aug 20, 2019
0
3
Patients with metastatic colorectal cancer who engaged in moderate exercise while undergoing chemotherapy tended to have delayed progression of their disease and fewer severe side effects from treatment, according to the ...
Aug 14, 2019
0
0
